Latvian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

EGCG Improves Acne by Modulating Molecular Targets

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
Saite tiek saglabāta starpliktuvē
StatussPabeigts
Sponsori
Seoul National University Hospital

Atslēgvārdi

Abstrakts

Epigallocatechin-3-gallate (EGCG) may improve acne vulgaris
- major polyphenolic constituent in green tea
- known as potent anti-carcinogenic, anti-inflammatory, anti-proliferative, and antimicrobial activities
- lipid-lowering and antiandrogenic properties was reported
- EGCG can improve acne vulgaris via one of the above mentioned actions.

Apraksts

Acne vulgaris is one of the most prevalent skin disorders of sebaceous follicles, affecting more than 85% of adolescents in United States. Acne can persist throughout the adulthood, and even a mild form of acne might progress to permanent scarring on the face, chest and back, thereby causing significant physical and psychosocial morbidities. Acne is a multifactorial disease of which etiology has not been fully elucidated, although considerable progress has been made in understanding its pathogenesis during last decade. The major pathogenic features of acne include abnormal ductal keratinization, sebum overproduction, Propionibacterium acnes, and inflammation. Common acne medications such as topical retinoids, antibiotics and isotretinoin are associated with irritation and incomplete responses, increased bacterial resistance or untoward side events, respectively. Thus there is a continuing need for a novel, effective agent targeting different aspects of acne pathogenesis, with minimal side effects.

In the recent decade, epigallocatechin-3-gallate (EGCG), the major polyphenolic constituent in green tea, has attracted much interest on account of its potent anti-carcinogenic, anti-inflammatory, anti-proliferative, and antimicrobial activities. Preclinical, observational, and clinical trial data have indicated that EGCG can inhibit tumor initiation, promotion, progression, and angiogenesis. EGCG also suppresses neutrophil chemotaxis, and has been suggested to improve many diseases that have inflammatory components such as diabetes, kidney injuries, arthritis, allergies, dental caries, cardiovascular, gastrointestinal, and neurodegenerative diseases. In skin, EGCG has been investigated mainly in light of antioxidative, immunopotentiating and anticarcinogenic properties against chemicals or ultraviolet irradiation. Moreover, EGCG has lipid-lowering and antiandrogenic properties, and can downregulate peroxisome proliferator-activated receptor-γ expression. Based on these observations, it can be inferred that EGCG might be effective in the treatment of acne.

Datumi

Pēdējoreiz pārbaudīts: 08/31/2012
Pirmais iesniegtais: 07/22/2010
Paredzētā reģistrācija iesniegta: 09/12/2012
Pirmais izlikts: 09/18/2012
Pēdējais atjauninājums iesniegts: 09/12/2012
Pēdējā atjaunināšana ievietota: 09/18/2012
Faktiskais studiju sākuma datums: 06/30/2005
Paredzamais primārās pabeigšanas datums: 05/31/2006
Paredzamais pētījuma pabeigšanas datums: 05/31/2006

Stāvoklis vai slimība

Acne Vulgaris

Iejaukšanās / ārstēšana

Other: topical EGCG application on acne

Fāze

-

Roku grupas

RokaIejaukšanās / ārstēšana
Active Comparator: Topical EGCG 1%
Seventeen subjects were designated to use 1% EGCG .Since baseline visits, affected areas of randomly allocated half sides were treated with 1% solution twice daily, whereas those of the opposite sides were treated with vehicle only (3% ethanol).
Experimental: topical EGCG 5%
Eighteen subjects were designated to use 5% EGCG, to evaluate a dose-response relationship. Since baseline visits, affected areas of randomly allocated half sides were treated with 5% EGCG solution twice daily, whereas those of the opposite sides were treated with vehicle only (3% ethanol).

Atbilstības kritēriji

Vecums, kas piemērots studijām 15 Years Uz 15 Years
Dzimumi, kas ir piemēroti studijāmAll
Pieņem veselīgus brīvprātīgos
Kritēriji

Inclusion Criteria:

- age of at least 15 years

- clinical diagnosis of mild to moderate acne vulgaris

Exclusion Criteria:

- known pregnancy or lactation

- any medical illness that might influence the results of the study,

- a previous history of oral acne medication or surgical procedures including laser treatment within 6 month and topical medication within 4 weeks of study enrollment.

Rezultāts

Primārie rezultāti

1. Assessment of acne severity [8 week after baseline]

Lesion counts of non-inflammatory lesions (closed comedone, open comedone) and severity measured by Reeds revised scale

Sekundārie iznākuma mērījumi

1. 2-mm punch biopsy of acne lesion on the EGCG-treated sides [8 week after baseline]

2. Standardized clinical photographs [8 week after baseline]

Pievienojieties mūsu
facebook lapai

Vispilnīgākā ārstniecības augu datu bāze, kuru atbalsta zinātne

  • Darbojas 55 valodās
  • Zāļu ārstniecības līdzekļi, kurus atbalsta zinātne
  • Garšaugu atpazīšana pēc attēla
  • Interaktīva GPS karte - atzīmējiet garšaugus atrašanās vietā (drīzumā)
  • Lasiet zinātniskās publikācijas, kas saistītas ar jūsu meklēšanu
  • Meklēt ārstniecības augus pēc to iedarbības
  • Organizējiet savas intereses un sekojiet līdzi jaunumiem, klīniskajiem izmēģinājumiem un patentiem

Ierakstiet simptomu vai slimību un izlasiet par garšaugiem, kas varētu palīdzēt, ierakstiet zāli un redziet slimības un simptomus, pret kuriem tā tiek lietota.
* Visa informācija ir balstīta uz publicētiem zinātniskiem pētījumiem

Google Play badgeApp Store badge